CClinicalTrials.gg
CompletedNCT01307696Updated Apr 28, 2014

Self-Expanding Multi-Layered Partially Resorbable Lightweight Polypropylene Mesh Device (Proceed Ventral Patch® Or Pvp®) For The Treatment of Small and Medium Umbilical Ventral Hernias

An observational study in Umbilical Hernia, sponsored by Algemeen Ziekenhuis Maria Middelares. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-04-28.

Sponsored by Algemeen Ziekenhuis Maria Middelares · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Meshes-devices using dual-sided mesh technology have been developed for the specific indication of small ventral hernias. The design of these meshes allows introduction of a mesh of appropriate size to cover the hernia defect, through a small incision. This technique is very attractive for the surgeon and the patients because the mesh usually can be introduced through a nearly invisible scar in the umbilicus. The avoidance of fixation sutures omits the pain related to these sutures. Short-term results and patient satisfaction are very favorable, encouraging the surgeons to continue with the technique, although long-term results of these meshes in good quality studies are lacking.

Read the detailed description

The aim of this study is to evaluate the safety and efficacy at 12 months after repair of small and medium ventral hernias using PVP™. All patients operated between March 2009 and February 2011 at the participating centers, will be evaluated and described. Patients will be evaluated by clinical investigation, questioning and ultrasound. The investigators' main focus will be the incidence of complications related to the use of the device, during the first year. Also the investigators look at recurrence rate at 12 months, occurrence of pain at 12 months and foreign body feeling. The trial can be seen as a quality control of a cohort of patients treated with an innovative mesh device. No sponsoring from the company J\&J will be asked or accepted.

02

Conditions studied

  • Umbilical Hernia

Keywords

  • Umbilical Hernia Repair
  • PVP Mesh
03

In context

Hernia, Umbilical

67 studies on the registry are indexed under Hernia, Umbilical; 13 are open to participants now.

This study's enrollment of 100 is below the median of 115 across 26 observational studies indexed under Hernia, Umbilical.

Browse Hernia, Umbilical studies →

Lead sponsor

Algemeen Ziekenhuis Maria Middelares is the lead sponsor of 36 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All patients that were treated at the participating centres with a PVP™ for the repair of an umbilical hernia or another abdominal wall hernia before February 2011, are eligible for the trial.

Inclusion criteria

  • All patients that were treated at the participating centres with a PVP™ for the repair of an umbilical hernia or another abdominal wall hernia before February 2011.

Exclusion criteria

Exclusion Criteria:

  • no informed consent from the patient.
  • patients lost to follow up.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (actual)
06

What researchers measure

Primary outcomes

  1. Hernia recurrence

    Time frame: 1 year

07

Study locations

1 site
  • AZ Maria Middelares
    Ghent, Oost Vlaanderen 9000, Belgium
08

References and documents

Publications

  • Bontinck J, Kyle-Leinhase I, Pletinckx P, Vergucht V, Beckers R, Muysoms F. Single centre observational study to evaluate the safety and efficacy of the Proceed Ventral Patch to repair small ventral hernias. Hernia. 2014 Oct;18(5):671-80. doi: 10.1007/s10029-013-1140-5. Epub 2013 Jul 24. PubMed 23881401 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01307696
Lead sponsor
Algemeen Ziekenhuis Maria Middelares
Responsible party
Jan Bontinck (Doctor, Algemeen Ziekenhuis Maria Middelares) — Principal investigator
First posted
Mar 3, 2011
Start date
Aug 2010
Primary completion
Apr 2014
Completion
Apr 2014
Last update
Apr 28, 2014

Study contacts

Jan Bontinck
principal investigator · Algemeen Ziekenhuis Maria Middelares

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion